SHE:301263 Revenue

Guangdong Taienkang Pharmaceutical had revenue of 184.66M CNY in the quarter ending March 31, 2025, a decrease of -2.35%. This brings the company's revenue in the last twelve months to 716.59M, down -5.23% year-over-year. In the year 2024, Guangdong Taienkang Pharmaceutical had annual revenue of 721.03M, down -5.23%.

Revenue (ttm)

716.59M

Revenue Growth

-5.23%

P/S Ratio

20.09

Revenue / Employee

662.89K

Employees

1,081

Market Cap

14.40B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	721.03M	-39.76M	-5.23%
Dec 31, 2023	760.79M	-22.69M	-2.90%
Jan 1, 2023	783.48M	129.83M	19.86%
Jan 1, 2022	653.65M	-55.33M	-7.80%
Dec 31, 2020	708.98M	212.59M	42.83%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Sichuan Biokin Pharmaceutical	5.82B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings